Sperling Prostate Center

Month: March 2024

The Biggest BPH Treatment Breakthrough Yet?

If it shrinks BPH, can it kill prostate cancer? That’s the question that sparked “the first long-term prospective randomized-controlled study of an intraprostatic molecular injectable treatment for low grade localized PCa to be reported.” The authors of the study include luminaries from sites such as Johns Hopkins and Mt. Sinai/Icahn School of Medicine... keep reading
WordPress Image Lightbox